Home The Action MC Substitutes/Other Dr. Mariarosaria Bucci (IT)


Dr. Mariarosaria Bucci

Assistant Professor in Pharmacology
Department of Experimental Pharmacology University of Naples "Federico II"
via Domenico Montesano 49 Naples Italy
80131 Naples

T: +39-81-678665
F: +39-81-678403
E: This email address is being protected from spambots. You need JavaScript enabled to view it.

Research Interests
vascular pharmacology; hydrogen sulfide; nitric oxide;  inflammation

Selected Recent Publications

  • Bucci M, Cantalupo A, Vellecco V, Panza E, Monti MC, Zampella A, Ianaro A, Cirino Perthamide C inhibits eNOS and iNOS expression and has immunomodulating activity in vivo. PLoS One. 2013;8(3):e57801.
  • Bucci M, Vellecco V, Harrington L, Brancaleone V, Roviezzo F, Mattace Raso G, Ianaro A, Lungarella G, De Palma R, Meli R, Cirino G. Cross-talk between toll-like receptor 4 (TLR4) and proteinase-activated receptor 2 (PAR(2) ) is involved in vascular function. Br J Pharmacol. 2013 Jan;168(2):411-20.
  • Bucci M, Papapetropoulos A, Vellecco V, Zhou Z, Zaid A, Giannogonas P, Cantalupo A, Dhayade S, Karalis KP, Wang R, Feil R, Cirino G. cGMP-Dependent Protein Kinase Contributes to Hydrogen Sulfide-Stimulated Vasorelaxation. PLoS One. 2012;7(12):e53319
  • Bucci M, Cigliano L, Vellecco V, D'Andrea LD, Ziaco B, Rossi A, Sautebin L, Carlucci A, Abrescia P, Pedone C, Ianaro A, Cirino G. ApoA-I mimetic peptide P2a by restoring cholesterol esterification unmasks ApoA-I anti-inflammatory endogenous activity in vivo. J Pharmacol Exp Ther. 2012 Mar;340(3):716-22
  • Bucci M, Papapetropoulos A, Vellecco V, Zhou Z, Pyriochou A, Roussos C, Roviezzo F, Brancaleone V, Cirino G. Hydrogen sulfide is an endogenous inhibitor of phosphodiesterase activity.Arterioscler Thromb Vasc Biol. 2010 Oct;30(10):1998-2004.



POLICY STATEMENT: Biomedicine and Molecular Biosciences Action BM1005 is funded by COST, through its implementing agent the European Science Foundation.